Sign in
Active, not recruitingNo phase

Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia

Key facts

Who runs it
Ruihua Wei
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
3,000 people, planned
Started
28 Sept 2020
Expected to end
28 Jul 2030
Type of study
Observational, 4 groups
Treatments tested
  • Red Light
Record updated
8 September 2025

Who can take part

Age
5 years to 16 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Ages 5 to 16, gender unrestricted
  • RLRL device usage duration of one year or more

Who cannot take part

  • Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
  • With congenital eye disease, such as congenital cataract, congenital retinal disease
  • Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
  • Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
  • Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
  • Children with obvious strabismus and amblyopia
  • Bnormal intraocular pressure and clinical significance (IOP \<10 mmHg or IOP \>21mmHg or binocular IOP difference ≥5mmHg)
  • Optic nerve damage or congenital optic nerve dysfunction
  • Can not be regularly checked
  • The adjustment range is less than 8D or obvious near difficulties
  • Other reasons researchers think it is not suitable for inclusion in researchers

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the long-term efficacy of repeated low-level red-light (RLRL) therapy in the prevention and control of myopia in children, and to analyze the key factors influencing its efficacy (such as individual differences and compliance), with the aim of providing evidence-based support for the optimization of clinical myopia prevention and control strategies.

The 4 groups in the trial

  • The RLRL-1year Group

    use red light 1 year

    Treatment: Red Light

  • The RLRL-2years Group

    Treatment: Red Light

  • The RLRL-3years Group

    Treatment: Red Light

  • The RLRL-more than 3 years

    use the RLRL-more than 3 years

    Treatment: Red Light

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study on the Long-term Efficacy Evaluation and Influencing Factors of Repeated Low-level Red-light Therapy in Myopia Prevention and Control in Children
Record updated
8 September 2025